Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation

被引:54
作者
Fanikos, J
Tsilimingras, K
Kucher, N
Rosen, AB
Hieblinger, MD
Goldhaber, SZ
机构
[1] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Ctr Clin Excellence, Boston, MA 02115 USA
关键词
D O I
10.1016/j.amjcard.2003.09.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We compared the efficacy, safety, and impact on postoperative hospital length of stay and inpatient hospital costs of low-molecular-weight heparin with that of unfractionated heparin as a "bridge" to achieving therapeutic levels of anticoagulation with warfarin in patients with newly implanted prosthetic heart valves. The patients who received low-molecular-weight heparin had a shorter length of stay and decreased postoperative costs compared with the control subjects receiving unfractionated heparin. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:247 / 250
页数:4
相关论文
共 11 条
[1]   Managing oral anticoagulant therapy [J].
Ansell, J ;
Hirsh, J ;
Dalen, J ;
Bussey, H ;
Anderson, D ;
Poller, L ;
Jacobson, A ;
Deykin, D ;
Matchar, D .
CHEST, 2001, 119 (01) :22S-38S
[2]   Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].
Bonow, RO ;
Carabello, B ;
de Leon, AC ;
Edmunds, LH ;
Fedderly, BJ ;
Freed, MD ;
Gaasch, WH ;
McKay, CR ;
Nishimura, RA ;
O'Gara, PT ;
O'Rourke, RA ;
Rahimtoola, SH ;
Ritchie, JL ;
Cheitlin, MD ;
Eagle, KA ;
Gardner, TJ ;
Garson, A ;
Gibbons, RJ ;
Russell, RO ;
Ryan, TJ ;
Smith, SC .
CIRCULATION, 1998, 98 (18) :1949-1984
[3]   Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A meta-analysis of randomized, controlled trials [J].
Gould, MK ;
Dembitzer, AD ;
Doyle, RL ;
Hastie, TJ ;
Garber, AM .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (10) :800-+
[4]   Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis [J].
Gould, MK ;
Dembitzer, AD ;
Sanders, GD ;
Garber, AM .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (10) :789-+
[5]   Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home [J].
Koopman, MMW ;
Prandoni, P ;
Piovella, F ;
Ockelford, PA ;
Brandjes, DPM ;
vanderMeer, J ;
Gallus, AS ;
Simonneau, G ;
Chesterman, CH ;
Prins, MH ;
Bossuyt, PMM ;
deHaes, H ;
vandenBelt, AGM ;
Sagnard, L ;
DAzemar, P ;
Buller, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :682-687
[6]   A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis [J].
Levine, M ;
Gent, M ;
Hirsh, J ;
Leclerc, J ;
Anderson, D ;
Weitz, J ;
Ginsberg, J ;
Turpie, AG ;
Demers, C ;
Kovacs, M ;
Geerts, W ;
Kassis, J ;
Desjardins, L ;
Cusson, J ;
Cruickshank, M ;
Powers, P ;
Brien, W ;
Haley, S ;
Willan, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :677-681
[7]   Low molecular weight heparin after mechanical heart valve replacement [J].
Montalescot, G ;
Polle, V ;
Collet, JP ;
Leprince, P ;
Bellanger, A ;
Gandjbakhch, I ;
Thomas, D .
CIRCULATION, 2000, 101 (10) :1083-1086
[8]   Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis [J].
O'Brien, B ;
Levine, M ;
Willan, A ;
Goeree, R ;
Haley, S ;
Blackhouse, G ;
Gent, M .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (19) :2298-2304
[9]   Use of Enoxaparin for the chronically anticoagulated patient before and after procedures [J].
Spandorfer, JM ;
Lynch, S ;
Weitz, HH ;
Fertel, S ;
Merli, GJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (04) :478-+
[10]  
Tinmouth AH, 2001, ANN PHARMACOTHER, V35, P669